Correction: MicroRNA-based integrated diagnosis and therapy for GBM: current status and advances - Summary - MDSpire

Correction: MicroRNA-based integrated diagnosis and therapy for GBM: current status and advances

  • By

  • Ye Chen

  • Huiyi Liu

  • Peipei Yuan

  • Yongqi Li

  • Changqiong Xu

  • Ran Li

  • Jibing Chen

  • Fasheng Wu

  • June 24, 2026

  • 0 min

Share

Objective:

To provide an updated overview of integrated diagnosis and treatment approaches using microRNA for glioblastoma.

Approach:
  • Correction on Funding: The funding statement was corrected to include support from multiple grants, including the Joint Project of Science and Technology Innovation of Jiangxi Provincial Health Commission.
  • Typographical Correction: The title of Section 2.2 was corrected from discussing downregulated miRNAs to upregulated miRNAs in GBM.
Key Findings:
  • An omitted funding source was added to the article.
  • The funding statement was corrected to reflect accurate financial support.
  • A typographical error in the section title regarding miRNAs was rectified.
Interpretation:

The updates ensure the accuracy of funding information and content regarding miRNA expression in glioblastoma.

Conclusion:

The article has been updated to correct funding and typographical errors.

Sources:

Original Source(s)

Related Content